OptiNose, Inc. (OPTN)
NASDAQ: OPTN · Real-Time Price · USD
5.77
-0.27 (-4.47%)
Feb 21, 2025, 4:00 PM EST - Market closed
OptiNose Employees
OptiNose had 132 employees as of December 31, 2023. The number of employees decreased by 9 or -6.38% compared to the previous year.
Employees
132
Change (1Y)
-9
Growth (1Y)
-6.38%
Revenue / Employee
$573,273
Profits / Employee
-$235,970
Market Cap
58.02M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
OPTN News
- 5 weeks ago - Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million - GlobeNewsWire
- 2 months ago - Optinose Announces 1-for-15 Reverse Stock Split - GlobeNewsWire
- 2 months ago - Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - OptiNose, Inc. (OPTN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights - GlobeNewsWire
- 3 months ago - Optinose Announces Reporting Date for Third Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Optinose Appoints Terry Kohler as Chief Financial Officer - GlobeNewsWire